A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold et al.
Saved in:
| Title: | A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis: Ruxolitinib Cream: Pediatric Maximum-Use Trial: L. S. Gold et al. |
|---|---|
| Authors: | Stein Gold, Linda1 LSTEIN1@hfhs.org, Bissonnette, Robert2, Forman, Seth3, Zaenglein, Andrea4, Kuo, YuTzu5, Angel, Brett5, Chen, Xuejun5, Kallender, Howard5, Paller, Amy S.6 |
| Source: | American Journal of Clinical Dermatology. Mar2025, Vol. 26 Issue 2, p275-289. 15p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
